Leadership
The SNBL CPC vision is dynamically executed throughout every phase of the operation—from the top down. Key leadership at SNBL CPC continues the successful tradition of parent company Shin Nippon Biomedical Laboratories, Ltd., Japan's largest and oldest CRO. Striving to offer the highest quality research services at every stage of the drug-development process, the SNBL CPC team brings a wealth of research experience and a collaborative spirit that uniquely positions the organization as a true champion for your pharmaceutical development initiatives.
Clinical Research Department
Stephan A. Bart, SR
Chief Medical Officer [CV-PDF]
Cheryl M. Duggan
Director of Clinical Operations [CV-PDF]
Mary Unruh
Associate Director of Operations [CV-PDF]
Joan Haywood
Pharmacist [CV-PDF]
Masaru Kaneko
Research Physician [CV-PDF]
Client Service & Partnership
Mohamed S. Al-Ibrahim
Chief Operating Officer & President [CV-PDF]
Ronit Litwack
Director of Business Development [CV-PDF]
Corporate Management
Ryoichi Nagata
Chairman & CEO, SNBL Clinical Pharmacology Center, Inc.
CEO, SNBL Group Companies
Ryoichi Nagata, M.D., Ph.D., is the Chairman and CEO of SNBL Clinical
Pharmacology Center, Inc. He heads SNBL Global Group as CEO & President, which includes
serving as CEO of SNBL USA, Ltd. (Everett, WA). [more...]
|
Print